Comparison of the in vivo pharmacokinetics and in vitro dissolution of branded versus generic efavirenz formulation in HIV-infected patients

Cristina Gervasoni, Sara Baldelli ChemD, Matteo Cerea, Giovanni Cenderello, Teresa Bini, Stefania Vimercati, Rosaria Iardino, Andrea Gazzaniga, Antonella D’Arminio Monforte, Emilio Clementi, Dario Cattaneo

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)420-422
JournalTherapeutic Drug Monitoring
Volume38
Issue number3
DOIs
Publication statusPublished - Dec 30 2016

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology

Cite this

Gervasoni, C., ChemD, S. B., Cerea, M., Cenderello, G., Bini, T., Vimercati, S., Iardino, R., Gazzaniga, A., D’Arminio Monforte, A., Clementi, E., & Cattaneo, D. (2016). Comparison of the in vivo pharmacokinetics and in vitro dissolution of branded versus generic efavirenz formulation in HIV-infected patients. Therapeutic Drug Monitoring, 38(3), 420-422. https://doi.org/10.1097/FTD.0000000000000273